The Venture Codex Logo

The Venture Codex

Overview

University-partnered venture firm creating science-based companies.

Founded

2015

Deals ยท 12mo

22

Stage focus

Seed
Series A
Series B

Geographic focus

United Kingdom
United States

Sector focus

Asset Management
Business Development
Finance
Higher Education
...

Investment portfolio

104rounds
NAMEDATESIZE
Sensible Biotechnologies
Oct 2026Led
$27 MSeries A
Living Optics
Oct 2026Participated
$20 MOther Equity
ReEmerge
Sep 2026Participated
$37 MSeries A
MCatalysis
Sep 2026Led
$5 MSeed
Mirae
Jul 2026Led
$5 MSeed
Vivid Dx
Jul 2026Led
$15 MSeed
MoA Technology
Jul 2026Led
$30 MSeries C
RQ Bio
Jun 2026Participated
$115 MSeries A
Applied Atomics
Jun 2026Led
$4 MSeed
Oxford Quantum Circuits
Jun 2026Participated
$350 MSeries C
Caudal Energy
May 2026Led
$6 MOther Equity
Fractile
May 2026Participated
$220 MSeries B
Sensible Biotechnologies
Oct 2026Led
$27 MSeries A
Living Optics
Oct 2026Participated
$20 MOther Equity
ReEmerge
Sep 2026Participated
$37 MSeries A
MCatalysis
Sep 2026Led
$5 MSeed
Mirae
Jul 2026Led
$5 MSeed
Vivid Dx
Jul 2026Led
$15 MSeed
MoA Technology
Jul 2026Led
$30 MSeries C
RQ Bio
Jun 2026Participated
$115 MSeries A
Applied Atomics
Jun 2026Led
$4 MSeed
Oxford Quantum Circuits
Jun 2026Participated
$350 MSeries C
Caudal Energy
May 2026Led
$6 MOther Equity
Fractile
May 2026Participated
$220 MSeries B
104
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Oxford Science Enterprises: 104 funding rounds are recorded in the selected participation categories.All available history.
Oxford Science Enterprises: 104 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed154
Series A928
Series B115
Series C+16
Other Equity1213

Monthly Deal Activity

Oxford Science Enterprises: 104 deals are recorded across 116 months.All available history.
Oxford Science Enterprises: 104 deals are recorded across 116 months. All available history
MonthDeals
Mar '171
Apr '170
May '170
Jun '171
Jul '171
Aug '170
Sep '171
Oct '170
Nov '170
Dec '170
Jan '182
Feb '180
Mar '180
Apr '180
May '182
Jun '181
Jul '180
Aug '181
Sep '182
Oct '181
Nov '181
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '191
Aug '191
Sep '191
Oct '190
Nov '190
Dec '190
Jan '201
Feb '201
Mar '200
Apr '203
May '202
Jun '203
Jul '201
Aug '200
Sep '200
Oct '200
Nov '201
Dec '203
Jan '211
Feb '211
Mar '211
Apr '211
May '210
Jun '210
Jul '211
Aug '213
Sep '210
Oct '210
Nov '210
Dec '211
Jan '222
Feb '221
Mar '221
Apr '221
May '222
Jun '222
Jul '222
Aug '220
Sep '220
Oct '221
Nov '222
Dec '221
Jan '232
Feb '231
Mar '231
Apr '231
May '230
Jun '231
Jul '231
Aug '230
Sep '232
Oct '230
Nov '231
Dec '231
Jan '240
Feb '240
Mar '240
Apr '241
May '242
Jun '242
Jul '243
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '251
Mar '251
Apr '250
May '251
Jun '250
Jul '251
Aug '250
Sep '250
Oct '254
Nov '251
Dec '251
Jan '262
Feb '260
Mar '261
Apr '262
May '263
Jun '263
Jul '263
Aug '260
Sep '262
Oct '262

Sector Breakdown

Oxford Science Enterprises: Health & Life Sciences is the largest displayed sector by deal count (60 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Oxford Science Enterprises: Health & Life Sciences is the largest displayed sector by deal count (60 deals). All available history
SectorDeals
Health & Life Sciences60
Space & Frontier Tech25
Hardware & Robotics22
AI & Machine Learning20
Enterprise Software14
Clean Energy & Sustainability11
Data, Analytics & IT11
Manufacturing10
Food & Agriculture7
Cybersecurity & Privacy6
Networks, Cloud & Communication6
Professional Services4
Social & Community Platforms4
Transportation & Logistics3
Consumer & Lifestyle3
Fintech3
AR/VR2
Education & Workforce1
Government & Defense1
Real Estate & Construction1
Marketing & Advertising1
Media & Entertainment1
Developer Tools1

Deal Size Distribution

Oxford Science Enterprises: 104 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Oxford Science Enterprises: 104 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M13
$5M-$10M19
$10M-$25M31
$25M-$50M22
$50M-$100M9
$100M-$250M9
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Oxford Science Enterprises: Europe has the largest recorded deal count among the displayed regions (91 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Oxford Science Enterprises: Europe has the largest recorded deal count among the displayed regions (91 deals). All available history
RegionDeals
Europe91
United States11
Rg19 6ab2
Oxford Science Enterprises: 20 co-investors are shown, with University of Oxford sharing 15 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Oxford Science Enterprises: Led accounts for 37% and participating for 63% of round participation.All available history.
Oxford Science Enterprises: Led accounts for 37% and participating for 63% of round participation. All available history
CategoryDeals (count)Share (%)
Led3837%
Participating6663%
Oxford Science Enterprises: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Oxford Science Enterprises: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1950%
Co-led1950%

Team

Alexis Dormandy

Chief Executive Officer

Alexis Zervoglos

Senior Partner (Technology)

Claire Brown

Partner ( Life Sciences)

Jim Wilkinson

Chief Financial Officer

Joel Schoppig

Vice-President of Strategy

Sam Harman

Senior investment associate

Siegfried Thun-Hohenstein

Life Sciences Investment Analyst